Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes
Clinical trial NCT02762578 · COMPLETED
Trial details
- NCT number
- NCT02762578
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2017-05-19
- Enrollment
- 543
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.